Quantum Cyber N.V
QUCY Healthcare Diagnostics & Research
Quantum Cyber N.V’s revenue for fiscal 2025 (year ended December 2025) was $537,100.00, down 39.9% from fiscal 2024. In the quarter to June 2026, EPS grew 96.0% and free cash flow grew 26.7%, each against the same quarter a year earlier.
Follow QUCY
Quantum Cyber N.V (QUCY) Altman Z-score
Quantum Cyber N.V's Altman Z-score for fiscal 2025 is −37.02, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −37.02 | (23.81) |
| FY2024 | −13.22 | (1.27) |
| FY2023 | −11.94 | (5.77) |
| FY2022 | −6.18 | (2.01) |
| FY2021 | −4.17 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (0.35) | — | −0.42 | |
| Retained earnings / total assets | (19.69) | — | −27.57 | |
| EBIT / total assets | (3.03) | — | −10.00 | |
| Market value of equity / total liabilities | 1.43 | — | 0.86 | |
| Sales / total assets | 0.10 | — | 0.10 | |
| Altman Z-score | Distress zone | −37.02 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −86.69 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| PRPO Precipio, Inc. compare | −2.4× |
| MDXH MDxHealth SA compare | −2.7× |
| BNR Burning Rock Biotech Limited Sponsored ADR compare | −3.0× |
| XGN Exagen Inc. compare | −4.6× |
| BDSX Biodesix, Inc. compare | −7.5× |
| IMDX Insight Molecular Diagnostics Inc. compare | −25.6× |
| QUCY Quantum Cyber N.V | −37.0× |
| MDXHF MedX Health Corp. compare | −157× |
| MBAI MBody AI Ltd. compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets